A panel of experts discuss the value of clinical pathways in MM disease management. Ryan Haumschild, PharmD, MS, MBA: Let’s talk about clinical pathways. We’ve seen pathways continue to emerge. One ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results